Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cognition enhancer on the clinical track at Dainippon

Sep. 21, 1998

Orion receives EU approval to market Parkinson's disease treatment

Sep. 21, 1998

Anergen in-licenses MHC II-peptide complex with potential applications in MS

Sep. 21, 1998

Search for 5-HT2C ligands at Organon leads to the full agonist Org-38457

Sep. 18, 1998

Yale University studies suggest potential new therapeutic target for schizophrenia

Sep. 18, 1998

Neurogen epilepsy drug candidate undergoes further preclinical trials

Sep. 17, 1998

IND filed for new insomnia drug candidate from Neurogen and Pfizer

Sep. 17, 1998

GW-273227, a sodium channel blocker for the treatment of pain

Sep. 17, 1998

Glaxo Wellcome studies lamotrigine analogues in the search for new anticonvulsants

Sep. 17, 1998

Astra Arcus develops first full, selective alpha7 nAChR agonist

Sep. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...